Stoke Therapeutics, Inc. STOK Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s change in other assets?
- Stoke Therapeutics, Inc. (STOK) reported change in other assets of $3.59M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s change in other assets changed year-over-year?
- Stoke Therapeutics, Inc.'s change in other assets increased by 191.7% year-over-year, from $1.23M to $3.59M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.